$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
英菲格拉替尼现在在上海能够买到吗?
2025-10-19 11:44:20
Check Details
英菲格拉替尼Truseltiq治疗胆管癌效果显著
2025-10-19 11:44:20
Check Details
佩米替尼片治疗胆管癌疗效如何?治疗时要注意什么
2025-10-19 11:44:20
Check Details
全球首个!美国FDA批准艾伏尼布用于治疗IDH1突变胆管癌
2025-10-19 11:44:20
Check Details
胆管癌靶向药佩米替尼(达伯坦)可显著提高疾病控制率
2025-10-19 11:44:20
Check Details
英菲格拉替尼能与食物同服吗?使用时要注意什么
2025-10-19 11:44:20
Check Details
英菲格拉替尼的用法用量是怎样的?
2025-10-19 11:44:20
Check Details
英菲格拉替尼用药剂量是多少?长期用会耐药吗
2025-10-19 11:44:20
Check Details
英菲格拉替尼哪儿能买,用法用量是怎样的?
2025-10-19 11:44:20
Check Details
英菲格拉替尼进医保了吗,药物不良反应是什么?
2025-10-19 11:44:20
Check Details
英菲格拉替尼疗效怎么样,有副作用吗?
2025-10-19 11:44:20
Check Details
英菲格拉替尼怎么吃,需要注意什么?
2025-10-19 11:44:20
Check Details
1
2
...
31
32
33
34
35
36
37
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
2
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
3
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
4
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
5
Vemurafenib (Zelboraf) Complete Medication Guide
6
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
7
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
8
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
9
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
10
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
11
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
12
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth